Biosite(R) Incorporated to Conduct 4th Quarter Results Conference Call

Search Blogs that Mention this News Release

Click this link to view linked Bookmarking Services

Click this link to view linked Blogging Services

Biosite(R) Incorporated to Conduct 4th Quarter Results Conference Call

    SAN DIEGO, Calif., Jan. 21 /PRNewswire-FirstCall/ -- Biosite Incorporated
(Nasdaq: BSTE) announces the following Webcast:

    Biosite Incorporated will announce 2004 fourth quarter results on
Wednesday, January 26, 2005 following the close of the market.  The Company
will webcast a conference call on the same day (January 26) at 1:30 p.m. PST.


     What:
     Biosite Announces 4th Quarter Results Conference Call

     When:
     Wednesday, January 26, 2005 at 1:30 p.m. Pacific Standard Time

     Where:
     http://phx.corporate-ir.net/playerlink.zhtml?c=69046&s=wm&e=1004110
     OR http://www.biosite.com

     How:
     Live over the Internet -- Simply log onto the web at the address above.

     Telephonic:
     US & International Dial #: 706-643-1834
     Conference ID# 3254959

     You may dial *0 at any time for Operator assistance

     Contact:
     Violet Garcia
     Corporate and Investor Relations
     Biosite Incorporated
     858.455.4808 ext. 3221
     email: vgarcia@biosite.com

    If you are unable to participate during the live webcast, the call will be
archived on the Biosite web site http://www.biosite.com until February 16, 2005 at
2:30 p.m. PST.  Phone replay number for US callers is 800-642-1687.
International callers can dial 706-645-9291.  Conference ID# 3254959.  The
telephone replay will be available until February 16, 2005.

    Company press releases may be found at http://www.biosite.com

    About Biosite:  A leader in the drive to advance diagnosis, Biosite
Incorporated is a research-based company dedicated to the discovery and
development of novel protein-based diagnostic tests that improve a physician's
ability to diagnose debilitating and life-threatening diseases.  The Company
combines integrated discovery and diagnostics businesses to access proteomics
research, identify proteins with high diagnostic utility, develop and
commercialize products and educate the medical community on new diagnostic
approaches that improve health care outcomes.  Biosite's Triage(R) brand rapid
diagnostic tests are used in approximately 50 percent of U.S. hospitals and in
more than 50 international markets.  Biosite's commercialized products include
the Triage BNP Test to aid in the diagnosis and severity assessment of heart
failure, the Triage Cardiac Panel to aid in the diagnosis of heart attacks and
the Triage Drugs of Abuse Products for the diagnosis of drug overdose.  These
tests can deliver critical diagnostic information to physicians within 10 to
20 minutes.  Information about Biosite can be found at http://www.biosite.com.

    (Minimum Requirements to listen to broadcast:  The Windows Media Player
software, downloadable free from:
http://www.microsoft.com/windows/windowsmedia/EN/default.asp and at least a
28.8Kbps connection to the Internet.)

SOURCE Biosite Incorporated

http://www.biosite.com
Company News On-Call:

http://www.prnewswire.com/comp/116737.html
CONTACT:
Nadine Padilla, Vice President, Corporate &
Investor Relations of Biosite Incorporated, +1-858-455-4808, ext.
3187